NPM1 and acute myeloid leukemia: Although activating signals such as ULBP1 can stimulate NK and T cell responses through engagement with the NKG2D receptor, their immunostimulatory effects may be attenuated by the concurrent upregulation of immune checkpoint molecules, further enabling immune evasion in NPM1-mutated AML (51).